Pacira BioSciences PCRX
NASDAQ PCRX
$25.20 -0.45 (-1.75%)
As of: Sep 30, 2026 · 11:38 AM EDT

Pacira BioSciences (PCRX) Non-Current Debt (2010 - 2026)

Updated

Pacira BioSciences (PCRX) recorded Non-Current Debt of $363.12 million in Q2 2026, up 271.2% from $97.83 million a year earlier but down 1.2% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Non-Current Debt (2010 - 2026) Analysis & Trends

At the end of FY2025, Pacira BioSciences reported Non-Current Debt of $372.19 million, down 3.0% from FY2024.

  • Annual Non-Current Debt has a four-year compound annual growth rate of 2.6% (FY2021 to FY2025).
  • Across earlier years, Non-Current Debt came in at $383.55 million in FY2024 (+232.9%), $115.2 million in FY2023 (-54.1%), $251.06 million in FY2022 (-25.1%) and $335.26 million in FY2021.
  • Quarterly Non-Current Debt has ranged from $97.83 million in Q2 2025 to $383.55 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Non-Current Debt rose in four of the last eight quarters, with growth averaging 123.2%.
  • Peak year-over-year performance for Non-Current Debt in the last five years was growth of 271.2% in Q2 2026, against a decline of 61.9% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $367.66 million (Q1 2026), $372.19 million (Q4 2025) and $376.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Pacira BioSciences 1.01 Bn 73.12 Mn 148.24 Mn 363.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 363.12 Mn
Mar 31, 2026 367.66 Mn
Dec 31, 2025 372.19 Mn
Sep 30, 2025 376.72 Mn
Jun 30, 2025 97.83 Mn
Mar 31, 2025 101.49 Mn
Dec 31, 2024 383.55 Mn
Sep 30, 2024 107.02 Mn
Jun 30, 2024 109.75 Mn
Mar 31, 2024 112.48 Mn
Dec 31, 2023 115.20 Mn
Sep 30, 2023 117.97 Mn
Jun 30, 2023 134.82 Mn
Mar 31, 2023 137.53 Mn
Dec 31, 2022 251.06 Mn
Sep 30, 2022 309.85 Mn
Jun 30, 2022 318.34 Mn
Mar 31, 2022 326.83 Mn
Dec 31, 2021 335.26 Mn
Jun 30, 2013 96.89 Mn
API Access

Pacira BioSciences Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PCRX&period=max&api_key=YOUR_API_KEY